ClearPoint Neuro, Inc.

CLPT Nasdaq SEC CIK 1285550
Follow ClearPoint Neuro Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $12.1M +36.3% vs same quarter last year
Net income −$7.5M −26.6% vs same quarter last year
EPS, diluted −$0.24 −14.3% vs same quarter last year
Operating cash flow −$20.1M −544% vs same quarter last year
Revenue by quarter
$7.8M
$8.5M
$9.2M
$8.9M
$10.4M
$12.1M
$10.9M
$12.1M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20M$40MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$37M−$25.5M
FY24$31.4M−$18.9M
FY23$24M−$22.1M
FY22$20.6M−$16.4M
FY21$16.3M−$14.4M
FY20$12.8M−$6.8M
FY19$11.2M−$5.5M
FY18$7.4M−$6.2M
FY17$7.4M−$7.2M
FY16$5.7M−$8.1M
FY15$4.6M−$8.4M
FY14$3.6M−$4.5M
FY13$3.9M−$7.1M
FY12$5.1M−$5.9M
FY11$3.8M−$8.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−300%−200%−100%0%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2561.4%−65.4%−69.1%
FY2460.9%−62.9%−60.3%
FY2356.8%−93.7%−92.2%
FY2265.8%−79.5%−80%
FY2168.2%−82.1%−88.4%
FY2071.1%−48.5%−52.9%
FY1964.9%−41%−49.4%
FY1866.9%−71.4%−83.8%
FY1760.7%−85.9%−97.1%
FY1654%−130.3%−140.4%
FY1556.7%−195.3%−183.9%
FY1446.5%−147.6%−125.5%
FY1363.8%−190.2%−180.3%
FY1289%−61.9%−116.2%
FY1182.8%−155.1%−217.7%
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$24.4M
FY24−$9.2M
FY23−$14.4M
FY22−$16.4M
FY21−$12.9M
FY20−$7.8M
FY19−$2.9M
FY18−$4.7M
FY17−$6M
FY16−$5.9M
FY15−$8.7M
FY14−$7.3M
FY13−$7.9M
FY12−$7.6M
FY11−$6.3M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • ClearPoint Neuro
  • Healthcare median
−300%−200%−100%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearClearPoint NeuroHealthcare median
FY25−69.1%−30.6%
FY24−60.3%−47%
FY23−92.2%−58%
FY22−80%−80.4%
FY21−88.4%−71.8%
FY20−52.9%−62.2%
FY19−49.4%−46.2%
FY18−83.8%−49.6%
FY17−97.1%−45.9%
FY16−140.4%−36%
FY15−183.9%−37.8%
FY14−125.5%−35.5%
FY13−180.3%−37.1%
FY12−116.2%−29.1%
FY11−217.7%−27.9%